uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020)
uniQure's (QURE) quarterly Non-Current Deffered Revenue came in at $22.4 million in Q3 2020, down 6.15% year-on-year from $23.9 million in Q4 2019, and down 2.76% quarter-over-quarter from $23.0 million in Q2 2020.
uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends
uniQure's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $22.4 million for Q3 2020.
- On a quarterly basis, Non-Current Deffered Revenue fell 6.15% year-over-year to $22.4 million in Q3 2020; TTM through Sep 2020 was $22.4 million, a 6.15% decrease from a year earlier, with the FY2019 full-year figure at $23.1 million, up 164.1% from the prior year.
- Non-Current Deffered Revenue slipped to $22.4 million in Q3 2020 per QURE's latest filing, from $23.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $67.9 million in Q3 2017 and bottomed at $6.8 million in Q4 2016.
- The 5-year median for Non-Current Deffered Revenue is $23.8 million (2019), against an average of $27.3 million.
- Across the five-year window, Non-Current Deffered Revenue surged 894.07% in 2017 and sank 87.0% in 2018, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $6.8 million in 2016, then jumped by 894.07% to $67.4 million in 2017, then sank by 87.0% to $8.8 million in 2018, then soared by 164.1% to $23.1 million in 2019, then slipped by 3.13% to $22.4 million in 2020.
- Per Business Quant, the three latest QURE Non-Current Deffered Revenue figures stand at $22.4 million (Q3 2020), $23.0 million (Q2 2020), and $23.7 million (Q1 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 22.41 Mn |
| Jun 30, 2020 | 23.05 Mn |
| Mar 31, 2020 | 23.71 Mn |
| Dec 31, 2019 | 23.14 Mn |
| Sep 30, 2019 | 23.88 Mn |
| Jun 30, 2019 | 26.35 Mn |
| Mar 31, 2019 | 27.47 Mn |
| Dec 31, 2018 | 8.76 Mn |
| Sep 30, 2018 | 29.85 Mn |
| Jun 30, 2018 | 32.85 Mn |
| Mar 31, 2018 | 36.15 Mn |
| Dec 31, 2017 | 67.41 Mn |
| Sep 30, 2017 | 67.86 Mn |
| Jun 30, 2017 | 8.49 Mn |
| Mar 31, 2017 | 8.09 Mn |
| Dec 31, 2016 | 6.78 Mn |
| Dec 31, 2015 | 6.25 Mn |